A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked up well against currently recommended vaccines in a phase 3 trial, according to findings published in JAMA.

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the ...

In a study published in the Journal of the American Medical Association, researchers from Moderna reported that the new combo ...

Side effects were injection site pain ... but has not yet been approved for a flu shot. Moderna believes mRNA could speed up production of flu shots compared with traditional processes that ...